ArticleP & T : a peer-reviewed journal for formulary management2017

Rolapitant (Varubi): A Substance P/Neurokinin-1 Receptor Antagonist for the Prevention of Chemotherapy-Induced Nausea and Vomiting.

Tamara Goldberg et al.PubMed ↗Full text ↗

No numbers read from the abstract.